Natural Biocon (India) Limited Submits Q4FY26 SEBI Compliance Certificate for Dematerialisation Process

Natural biocon (India) Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

Regulatory Compliance Submission

The company filed the mandatory certificate under Regulation 74(5) of SEBI Depositories Regulations on April 06, 2026. Managing Director Arunkumar Dashrathbhai Prajapati digitally signed the submission, confirming the company's adherence to regulatory protocols for the fourth quarter of FY26.

Parameter	Details
Quarter Ended	March 31, 2026
Submission Date	April 06, 2026
Script Code	543207
ISIN	INE06MM01016
Signatory	Arunkumar Dashrathbhai Prajapati
DIN	08281232

Registrar Confirmation

MCS Share Transfer Agent Limited, serving as the company's Registrar and Transfer Agent, provided the confirmation certificate dated April 2, 2026. The registrar certified that all securities received from depository participants for dematerialisation during Q4FY26 were properly processed and confirmed to depositories.

The registrar confirmed compliance with key regulatory requirements:

Securities received for dematerialisation were accepted or rejected as appropriate
All securities have been listed on stock exchanges where earlier issued securities are listed
Security certificates received for dematerialisation were mutilated and cancelled after verification
Depository names were substituted in the register of members within the mandated 15-day period

Corporate Information

Natural Biocon (India) Limited operates from its registered office at A-1007, Sankalp Iconic Tower, S.G. Highway, Ahmedabad, Gujarat. The company maintains its corporate identification number L24299GJ1992PLC018210 and GST registration 24AAACN6841KIZD.

The quarterly compliance certificate demonstrates the company's commitment to maintaining proper dematerialisation processes and regulatory adherence as required under SEBI guidelines for listed entities.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+4.60%	+8.33%	-17.08%	-38.51%	-74.40%	-77.74%

Natural Biocon India Limited has announced the successful completion of its independent directors meeting held on March 20, 2026, in accordance with regulatory requirements under the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015.

Meeting Details and Compliance

The meeting was conducted pursuant to Regulation 25(3) of the Securities and Exchange Board of India (LODR) Regulations, 2015, read with Schedule IV of the Companies Act, 2013. This annual meeting represents a mandatory governance requirement for listed companies to ensure independent oversight of board operations.

Parameter:	Details
Meeting Date:	March 20, 2026
Duration:	02:00 P.M. to 03:15 P.M.
Venue:	Registered Office
Regulatory Framework:	SEBI LODR Regulations, 2015

Key Agenda Items Reviewed

The independent directors present at the meeting transacted several critical governance matters as part of their oversight responsibilities. The meeting agenda encompassed comprehensive performance evaluations and assessments across multiple dimensions of board effectiveness.

The directors undertook the following key activities:

Board Performance Review: Comprehensive evaluation of non-independent directors and assessment of the board of directors' collective performance
Chairperson Assessment: Detailed review of the chairperson's performance, incorporating perspectives from both executive and non-executive directors
Information Flow Analysis: Critical assessment of the quality, quantity, and timeliness of information exchange between company management and the board of directors

Governance and Transparency

This independent directors meeting forms part of Natural Biocon India Limited's commitment to maintaining robust corporate governance standards. The evaluation process ensures that the board operates effectively and that directors have access to necessary information for informed decision-making.

The company has duly informed BSE Limited about the meeting outcome, maintaining transparency with stakeholders and regulatory compliance. The notification was signed by Managing Director Arunkumar Prajapati (DIN: 08281232), confirming the completion of this mandatory governance exercise for Financial Year 2025-26.